Ulrike Verzetnitsch joined apceth Biopharma in 2015 as Chief Technical Officer. In this role, she is responsible for all GMP operation activities, including the manufacturing and quality control of apceth Biopharma’s own products and the CMO-business.
Ulrike Verzetnitsch began her career at Baxter in Vienna in 2000. Within Baxter, she was responsible for final container production of aseptic blood plasma products, vaccines and recombinants of commercial and clinical products. In 2010 she joined Takeda, where she was responsible for manufacturing of aseptic/sterile liquid and lyophilized as well as non-sterile liquid and semi-solid commercial products.